Hooper Holmes (HH) 8-K Other Events

September 2006

EXHIBIT 99.1

Certain information contained herein includes information

that is forward-looking. The matters referred to in forward-

looking statements may be affected by the risks and

uncertainties involving the Company’s business. These

forward-looking statements are qualified in the entirety by

cautionary statements contained in the Company’s Securities

and Exchange Commission filings. The Company disclaims

any obligation to update these forward-looking statements.

2

Hooper Holmes ~ Who We Are

•

#1 provider of health

information services for the life

and health insurance industry

•

Leading provider of

Independent Medical

Examinations (IME) for casualty

and property insurance

•

More than 250 locations in all

fifty states and U.K.

•

Long-standing customer

relationships with top the 100

insurers

•

New leadership team

•

(AMEX: HH)

$38.5 M

12%

$281.8 M

88%

Health Information Division

Claims Evaluation Division

2005 Revenues

3

A Look Inside…

Health Information

Division

Claims Evaluation

Division

MAAS

4

Investment Highlights

•

#1 market position in core businesses

•

Emerging leader in workers compensation

independent medical examinations

•

International presence

•

Loyal base of blue-chip clients

•

Strong balance sheet with no debt

•

Committed and talented group of employees

•

Strategic review underway to reduce costs, improve

operational performance and build for the future

•

Opportunity to leverage core skills of providing

medical services in growth markets

5

An Industry in Transition…

•

Consolidation

•

Competition from banks and larger carriers

•

Downward trends in life insurance rates

•

Underwriter customers under pressure

•

Demand for higher value-added products

•

Reinsurers

increasing demand for process effectiveness

…Creates Opportunity for HH

The Market

6

Long-Standing Relationships with

Blue-Chip Customers

•

Retained 42 of top 45 clients over last 25 years

•

Market leader with approximately 45% of the

Portamedic market share in the U.S.

•

Almost all major U.S. and U.K. life insurance

companies are customers

7

1.

Identify cost savings and opportunities

•

Customer focused approach

2.

Deliver maximum efficiency across the business

•

Examine each function within each division

•

Process improvement, service enhancement,

staffing levels, reinvestment criteria

•

Identify new opportunities to leverage skill

set/products

3.

Regular updates to shareholders

2006 Strategic Review -

Goals

8

2006 Strategic Review -

Implementation

Q3’07

Q2’07

Q4’07

Q1’07

Q4’06

Q3’06

Q2’06

Phase 3

Phase 2

Phase 1

Update on Q3

Earnings Call

Revenue

Enhancement

Expense

Management

Growth

Investment

20 Week Plan -

Underway

9

Phase 1-

Expense Management

•

Align costs with existing levels of revenues to restore

operating margins

•

Make better use of assets (i.e. Portamedic branch offices

and branch office personnel)

•

Complete integration of operations of CED-acquired

companies

•

Enhance operational controls on a Company-wide basis

•

Enhance information technology platform to generate cost

efficiencies

•

Consolidate regional service centers into a national service

center

2006 Strategic Review -

Implementation

Improving Efficiency

10

Phase 2 -

Revenue Enhancement

•

Seek opportunities for service enhancement and increased

flexibility or pricing

•

Add new services that enable HH to get closer to customers

•

Augment sales & marketing resources dedicated to growth

businesses

•

Continue to expand the business within the CED’s

core

customer base

•

Introduce new products and services

2006 Strategic Review -

Implementation

Innovating for Critical Customer Need

11

Phase 3 -

Growth Investment

•

Determine an optimal growth strategy based on core

capabilities

•

Screen organic and acquisition opportunities for growth,

profitability and risk

2006 Strategic Review -

Implementation

Innovating for Critical Customer Need

12

Health information to reduce underwriting risk

Three-to-five-day response time

Unmatched geographic coverage

Electronic information-gathering

Medical history, physician’s statements

Full service call center in Kansas City

National reference laboratory at 65% capacity

FDA approved kit manufacturer

Serves 92% of all UK life assurance companies

Field examinations and walk-in clinics

Unique digital data capture technology

Outsourced underwriting

Over 270,000 cases per year

Health Information Division

MAAS

13

Services Provided:

•

Independent Medical Exams

•

Peer Reviews

•

Radiology Reviews

•

Functional Capacity Evaluations

•

Bill Reviews

•

National Case Management for IMEs

•

#2 provider in Independent Medical Examination Market

•

Diversified Business Unit –

145,000 IMEs

(Independent Medical

Exams)

Claims Evaluation Division

Target Markets:  Auto

No-fault

Workers Comp

Disability

General Liability

14

Revitalized Leadership Team

15

Financial

Highlights

Revenue

$82.0

$84.4

$77.4

$76.5

$76.8

$75.6

$70.0

$72.0

$74.0

$76.0

$78.0

$80.0

$82.0

$84.0

$86.0

Q1

Q2

Q3

Q4

Q1

Q2

2005

2006

17

Gross Margin %

28.3%

28.1%

23.4%

21.3%

24.1%

24.9%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

Q1

Q2

Q3

Q4

Q1

Q2

2005

2006

18

SG&A Expense

* Above amounts exclude goodwill impairment and restructuring charges.

REV%

22.7%     21.9%       22.6%    27.3%       25.3%     25.4%

$18.6

$18.5

$17.5

$20.9

$19.4

$19.2

$15.0

$16.0

$17.0

$18.0

$19.0

$20.0

$21.0

Q1

Q2

Q3

Q4

Q1

Q2

2005

2006

19

Operating Income

* Above amounts exclude goodwill impairment and restructuring charges.

$4.6

$5.2

$0.6

($0.9)

($4.6)

($0.4)

($5.0)

($3.0)

($1.0)

$1.0

$3.0

$5.0

1

EPS

$0.04        $0.05         $0.00       ($0.05)      ($0.01)      ($0.00)

2005                                                       2006

Q1                Q2                 Q3                Q4      

Q1                Q2

20

(in millions)

6/30/06

12/31/05

Cash & Securities

$  4.7

$  11.7

Working Capital

32.2

33.8

Total Assets

$160.6

$ 162.3

Short-Term Borrowings

-

1.0

Long-Term Debt

-

-

Shareholders’

Equity

128.1

128.9

Current Ratio

2.0:1

2.0:1

DSOs

51 days

51 days

Period Ending

Balance Sheet

21

Summary

•

Strong business

fundamentals, weak

performance

•

Leading provider of

health information

services

•

Strong balance sheet

with no debt

•

New leadership team…

•

…improving efficiency

and…

•

…Planning for

innovation based on

customer need

22

September 2006